Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRACDICAL Study
NL-OMON31049Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in diabetes mellitus (DM) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Cardiovascular complications and all-cause death. Started Dec 2008; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NL-OMON31049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31049.